CERVARIX
Iraq – Federal (Baghdad) Opposition closed
Some details of this record were read from an image by OCR. Check them against the official bulletin.
| Notice | Application |
|---|---|
| Application no. | 90063 |
| Filing date | 25 Sep 2022 |
| Nice classes | 5 |
| Owner | GlaxoSmithKline Biologicals SA |
| Address | Rue de l’Institut 89, B-1330 Rixensart, Belgium |
| Country | Belgium |
| Bulletin | No. 1414, first announced 19 Oct 2023, page 173 |
| Opposition deadline | 17 Jan 2024 (90 days from the last announcement; confirm with the office) |
| Official source | Open the official bulletin (PDF) |